← Back to all signals
RESEARCH PAPER ANALYSIS

Social Vulnerability and the Relationship Between Maternal Caregiver Condition Management Ability and Transition Readiness in Young Adult Survivors of Childhood Brain Tumors.

In 53 maternal caregivers of young adult childhood brain tumor survivors living at home, cognitive late effects were associated with poorer transition readiness, while caregiver condition management ability showed a limited and subscale-dependent explanatory relationship among less socially vulnerable families.

Open original publication →
PMID42596094
JournalJournal of adolescent and young adult oncology
Publication Date2026-08-13
Ingested2026-08-17 12:23 AM
EXECUTIVE SUMMARY

What the AI sees

In 53 maternal caregivers of young adult childhood brain tumor survivors living at home, cognitive late effects were associated with poorer transition readiness, while caregiver condition management ability showed a limited and subscale-dependent explanatory relationship among less socially vulnerable families.

WHY IT MATTERS

Research significance

The reported evidence suggests that cognitive late effects are relevant to transition readiness and that caregiver condition management ability may contribute in some better-resourced families; by inference, cognitive-support and caregiver-management interventions could improve transition preparation, but this observational analysis did not test therapeutic efficacy.

ABSTRACT

Source abstract

PURPOSE: To utilize the social-ecological model of adolescent and young adult readiness to transition to understand the interplay of social determinants of health with condition management ability (CMA) of caregivers of young adult survivors of childhood brain tumors (YAS). METHODS: Maternal caregivers (N = 53) of 18- to 29-year-old YAS ≥2 years off-treatment living at home were screened into a problem-solving intervention randomized trial based on their risk of poorer CMA. They completed the Transition Readiness Assessment Questionnaire (TRAQ) and rated YAS cognitive late effect severity prior to randomization. Medical experts scored cognitive medical sequelae and treatment intensity. Social vulnerability was rated using the CDC/ATSDR social vulnerability index. RESULTS: CMA was not related to transition readiness when accounting for cognitive late effects. Cognitive late effects were associated with transition readiness (p < 0.01). For families with less social vulnerability, higher cognitive late effects were associated with poorer CMA, which was in turn related to lower managing daily activities and tracking health issues subscales of transition readiness. There were no other significant relationships. CONCLUSION: For families with more resources, CMA may explain the relationship between cognitive late effects and transition readiness, although findings were inconsistent by the TRAQ subscale. Additional investigation of social vulnerability in CMA and transition readiness is needed. Findings highlight the saliency of mitigating cognitive late effects resulting from childhood brain tumors and their treatment. There is a significant need for ongoing resources to support both ongoing condition management and transition readiness in the period of young adulthood for YAS.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Biomarker-Negative and MIBG-Negative Neuroblastoma Presenting as an Indeterminate Retroperitoneal Mass in a Young Child. Pediatrics international : official journal of the Japan Pediatric Society 29.85 2 Hypophosphatemic rickets in children: current knowledge and a proposal for a diagnostic algorithm. Endokrynologia Polska 58.0 3 Effectiveness of the "Golden Hour" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia. Boletin medico del Hospital Infantil de Mexico 65.0 4 Clinical validation of the nursing diagnosis of inadequate nutritional intake in children with cancer. International journal of nursing knowledge 67.6 5 Exploratory Analysis of the Inhibitory Effects of Propranolol on NLRP3 and Pyrin Inflammasomes. ACR open rheumatology 56.76 6 First-In-Human Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of Tilpisertib Fosmecarbil (GS-5290), an Oral Prodrug of a Tumor Progression Locus 2 Inhibitor in Healthy Participants. Journal of clinical pharmacology 84.72 7 Dyadic Latent Profiles of Sexual and Reproductive Distress in Young Adult Cancer Survivors and Their Partners: A Cross-Sectional Analysis. Psycho-oncology 61.0 8 Disproportionality analysis of drug-induced myocarditis: Insights from the Food and Drug Administration Adverse Event Reporting System database. The Journal of international medical research 63.68 9 Innovative Insights into Osteosarcoma: Unraveling the Role of LncRNAs, miRNAs, and CircRNAs in Tumorigenesis and Therapeutic Resistance. Current gene therapy 63.84 10 Targeting Metal-Dependent Cell Death in Cancer: From Molecular Circuitry to Biomarker-Guided Precision Combination Therapy. Current cancer drug targets 70.99 11 Long-term outcomes of non-operative compared to operative management of acute uncomplicated appendicitis - a systematic review and meta-analysis. American journal of surgery 72.5 12 What have I missed again: A qualitative study exploring parents of children with cancer's experiences of fear of missing out. Journal of health psychology 54.0 13 Radiographic overestimation of inferior vena cava involvement in pediatric neuroblastoma: a case report. Journal of surgical case reports 55.5 14 Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021. Cancer innovation 56.0 15 Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. The American journal of case reports 53.92 16 Modern management and multidisciplinary care of bladder prostate rhabdomyosarcoma. Current opinion in pediatrics 62.8 17 Improving Dietary Data Quality in Nutrition Studies: Development and Validation of an Explainable, Reproducible, Open Machine Learning-Assisted Framework for Outlier Detection in 24-Hour Recalls. American journal of epidemiology 61.5 18 Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines. Journal of adolescent and young adult oncology 65.5 19 Seen, Heard, and Still Missing: Understanding Clinical Trial Nonparticipation Among Women of Color. Journal of adolescent and young adult oncology 74.5 20 Correction to "Health-Related Quality of Life in Chinese Children and Adolescents With Cancer: A Systematic Review and Meta-Analysis". International journal of cancer 63.0 21 Evolution of robotic-assisted resection of pediatric neuroblastic tumors: a retrospective analysis. Updates in surgery 61.5 22 Late cardiac effects of anthracycline-based therapy in childhood cancer survivors: a CMR study of cardiac strain and function. Clinical research in cardiology : official journal of the German Cardiac Society 68.34 23 Biological reconstruction in the growing child after tumour resection: long-term outcomes of vascularized fibular epiphyseal transfer. International orthopaedics 57.2 24 Neuroimaging findings of the hypothalamus and pituitary gland in children with growth hormone deficiency: a 25-year single-center retrospective study. Hormones (Athens, Greece) 67.0 25 Ovarian Lymphoma and Bone Metastasis Presenting With Paraparesis in an Adolescent: A Case Report. The American journal of case reports 51.9 26 Evaluating the impact of virtual oncology financial and legal navigation on cancer-related financial toxicity. JNCI cancer spectrum 63.12 27 Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group. Journal of the National Cancer Institute 65.4 28 Impact of Satisfactory Family Coping on the Mental Health of Parents Whose Children Died of Cancer. Journal of pain and symptom management 59.5 29 Surgical approach to solid breast masses in girls. Journal of pediatric and adolescent gynecology 58.4 30 Pediatric and Adolescent Gynecological Tumors and Associated Predisposition Syndromes. Journal of pediatric and adolescent gynecology 56.0 31 Facial nerve schwannoma of the accessory parotid gland region in a child managed through a transoral approach. BMJ case reports 56.0 32 Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study. The Lancet. Oncology 85.2
PATIENT-FRIENDLY SUMMARY

Social Vulnerability and the Relationship Between Maternal Caregiver Condition Management Ability and Transition Readiness in Young Adult Survivors of Childhood Brain Tumors.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic